BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the Australian Parliament in passing the Export […]
Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make it available over the counter in […]
Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs, sales strategy, growing product sales, partnering […]
In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]
A scientific study conducted by Professor Poulas Konstantinos and his team from the Department of Pharmacy at the University of Patras in Greece, and in collaboration […]
Even on a good day, eight-year-old Sophie Martin has hundreds of seizures. When she has a severe seizure, she turns blue and cannot breathe. She has […]